- Filed
- May 8, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 4, 2026 | 197.21M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 210.87M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 531.23K sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$10.65M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$514K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $16.88M |
| Cash And Equivalents restated | Q1 2026 · Mar 31, 2025 | $1.38M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $1.74B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $2.42B |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | $2.09M |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | $2.08M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $5.44M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $12.75M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $5.44M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $12.75M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $18.03M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $31.15M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $1.74B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $2.43B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$3.25 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$1.84 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$3.25 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$1.84 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $9.88M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $1.06M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$685.56M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$975K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$684.58M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$926K |